Design Therapeutics Inc (DSGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 19,706 | 18,169 | 19,311 | 21,569 | 20,418 |
| Operating Income | -19,706 | -18,169 | -19,311 | -21,569 | -20,418 |
| Other Income | 2,070 | 2,172 | 2,314 | 2,486 | 2,703 |
| Pre-tax Income | -17,636 | -15,997 | -16,997 | -19,083 | -17,715 |
| Net Income Continuous | -17,636 | -15,997 | -16,997 | -19,083 | -17,715 |
| Net Income | $-17,636 | $-15,997 | $-16,997 | $-19,083 | $-17,715 |
| EPS Basic Total Ops | -0.29 | -0.27 | -0.30 | -0.34 | -0.31 |
| EPS Basic Continuous Ops | -0.29 | -0.27 | -0.30 | -0.34 | -0.31 |
| EPS Diluted Total Ops | -0.29 | -0.27 | -0.30 | -0.34 | -0.31 |
| EPS Diluted Continuous Ops | -0.29 | -0.27 | -0.30 | -0.34 | -0.31 |
| EPS Diluted Before Non-Recurring Items | -0.29 | -0.27 | -0.30 | -0.34 | -0.31 |
| EBITDA(a) | $-19,696 | $-18,525 | $-19,923 | $-22,331 | $-21,319 |